ArticleVeterinary research2025
Chicken PIAS2 enhances H6N2 avian influenza virus replication by promoting SUMOylation of viral NP.
Article in Veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Post-translational modification networks as master regulators of influenza virus replication, host adaptation, and immune evasion.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Avian influenza virus (AIV) is a significant zoonotic pathogen that causes infectious disease in various species and poses a serious threat to both the poultry industry and public health. Mammalian protein inhibitors of activated STAT2 (PIAS2) have been shown to affect viral replication by interacting with viral proteins. However, the role of chicken PIAS2 (chPIAS2) in regulating H6N2 subtype AIV replication remains unclear. In this study, we cloned chPIAS2 from primary chicken embryo fibroblast cells and identified that it contains five conserved domains. Overexpression of chPIAS2 promoted the replication of H6N2 AIV, although chPIAS2 expression was also induced during viral infection. We further found that chPIAS2 interacted with the H6N2 AIV nucleoprotein (NP) (DK65-NP) in the nucleus. ChPIAS2 promoted the SUMOylation of DK65-NP through its SUMO E3 ligase activity. We also confirmed that the lysine residues at positions 7, 48, 77, and 113 are the small ubiquitin-like modifier (SUMO) conjugation (SUMOylation) sites of DK65-NP. Collectively, our results indicate that chPIAS2 promotes H6N2 AIV replication by enhancing the SUMOylation of viral NP. In conclusion, our study reveals the role of chPIAS2 in AIV replication and provides new insights into the molecular mechanisms underlying AIV pathogenicity in poultry, suggesting a potential therapeutic target for avian influenza.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.